Tumor lysis syndrome historical perspective

Jump to navigation Jump to search

Tumor lysis syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tumor lysis syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Tumor lysis syndrome historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tumor lysis syndrome historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tumor lysis syndrome historical perspective

CDC on Tumor lysis syndrome historical perspective

Tumor lysis syndrome historical perspective in the news

Blogs on Tumor lysis syndrome historical perspective

Directions to Hospitals Treating Tumor lysis syndrome

Risk calculators and risk factors for Tumor lysis syndrome historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Mohamad Alkateb, MBBCh [2]

Overview

Tumor lysis syndrome was first discovered in 1929 in patients with chronic leukemia. Spontaneous tumor lysis syndrome was first discovered by Crittenden and Ackerman in 1977.

Historical Perspective

Tumor lysis syndrome was first discovered in 1929 in patients with chronic leukemia.[1] Spontaneous tumor lysis syndrome was first discovered by Crittenden and Ackerman, in 1977.[2]

References

  1. Davidson MB, Thakkar S, Hix JK, Bhandarkar ND, Wong A, Schreiber MJ (2004). "Pathophysiology, clinical consequences, and treatment of tumor lysis syndrome". Am J Med. 116 (8): 546–54. doi:10.1016/j.amjmed.2003.09.045. PMID 15063817.
  2. Crittenden DR, Ackerman GL (1977). "Hyperuricemic acute renal failure in disseminated carcinoma". Arch Intern Med. 137 (1): 97–9. PMID 831657.

Template:WH Template:WS